Companies / Petros Pharmaceuticals, Inc.

Petros Pharmaceuticals, Inc.

OTC: PTPICIK 1815903NEW YORK, NY

Financials · FY2024

Revenue$5.11M
Net income$1.91M
Total debt$1.74M
Cash$3.49M
Diluted EPS$-1.56
Shares outstanding42.4M

Ownership

42.4M shares outstanding · as of May 12, 2026
17.3%Insiders
Ownership
Insiders17.30%7,329,103
Public float82.70%35,043,157

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 5

View all →
Insider% of sharesShares
Silverman JoshuaDirector
10.42%4,415,450
Bernstein BruceDirector
4.45%1,887,334
Boctor FadySee Remarks
1.23%519,986
Walker Wayne RemellDirector
1.19%506,333
Weinstein RobertChief Accounting Officer
——

Institutional holders 0

HolderValue% of shares
No institutional holders on file.

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 2, 2026Boctor Fady
Executive
GrantCommon Stock$0+500K
+2501.75%
519,986
1.23% of shares
low
Jan 2, 2026Silverman Joshua
Director
GrantCommon Stock$0+4.4M
+10815.82%
4,415,450
10.42% of shares
low
Jan 2, 2026Walker Wayne Remell
Director
GrantCommon Stock$0+500K
+7895.15%
506,333
1.19% of shares
low
Jan 2, 2026Bernstein Bruce
Director
GrantCommon Stock$0+1.9M
+15201.88%
1,887,334
4.45% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Iroquois Capital Management, LLCPassive13G/A———